+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In Vitro and In Vivo Evaluation of Essential Oil from Artemisia absinthium L. Formulated in Nanocochleates against Cutaneous Leishmaniasis



In Vitro and In Vivo Evaluation of Essential Oil from Artemisia absinthium L. Formulated in Nanocochleates against Cutaneous Leishmaniasis



Medicines 4(2):



Background: Leishmaniasis is a zoonotic disease caused by protozoan parasites from Leishmania genus. Currently, there are no effective vaccines available and the available therapies are far from ideal. In particular, the development of new therapeutic strategies to reduce the infection caused by Leishmania amazonensis could be considered desirable. Different plant-derived products have demonstrated antileishmanial activity, including the essential oil (EO) from Artemisia absinthium L. (EO-Aa), Asteraceae. Methods: In the present study, the EO-Aa formulated in nanocochleates (EO-Aa-NC) was investigated in vitro against intracellular amastigotes of L. amazonensis and non-infected macrophages from BALB/c mice. In addition, the EO-Aa-NC was also evaluated in vivo against on experimental cutaneous leishmaniasis, which body weight, lesion progression, and parasite load were determined. Results: EO-Aa-NC displayed IC50 values of 21.5 ± 2.5 μg/mL and 27.7 ± 5.6 μg/mL against intracellular amastigotes of L. amazonensis and non-infected peritoneal macrophage, respectively. In the animal model, the EO-Aa-NC (30 mg/kg/intralesional route/every 4 days 4 times) showed no deaths or weight loss greater than 10%. In parallel, the EO-Aa-NC suppressed the infection in the murine model by approximately 50%, which was statistically superior (p < 0.05) than controls and mice treated with EO-Aa. In comparison with Glucantime®, EO-Aa-NC inhibited the progression of infection as efficiently (p > 0.05) as administration of the reference drug. Conclusions: Encochleation of EO-Aa resulted in a stable, tolerable, and efficacious antileishmanial formulation, facilitating systemic delivery of EO, with increased activity compared to administration of the free EO-Aa. This new formulation shows promising potential to future studies aimed at a new therapeutic strategy to treat leishmaniasis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059885954

Download citation: RISBibTeXText

PMID: 28930253

DOI: 10.3390/medicines4020038


Related references

In vitro evaluation of antileishmanial activity and toxicity of essential oils of Artemisia absinthium and Echinops kebericho. Chemistry and Biodiversity 8(4): 614-623, 2011

Determination of the chemical composition and antioxidant activity of the essential oil of Artemisia dracunculus and of the antifungal and antibacterial activities of Turkish Artemisia absinthium, A. dracunculus, Artemisia santonicum, and Artemisia spicigera essential oils. Journal of Agricultural and Food Chemistry 53(24): 9452-9458, 2005

Anti microbial activities of the essential oils of artemisia absinthium artemisia vestita and artemisia vulgaris. Indian Journal of Pharmacy 38(1): 21-22, 1976

Chemical characterization by GC-MS and in vitro activity against Candida albicans of volatile fractions prepared from Artemisia dracunculus, Artemisia abrotanum, Artemisia absinthium and Artemisia vulgaris. Chemistry Central Journal 8(1): 6, 2014

In vitro and in vivo antileishmanial activity of Artemisia annua L. leaf powder and its potential usefulness in the treatment of uncomplicated cutaneous leishmaniasis in humans. Revista Da Sociedade Brasileira de Medicina Tropical 50(1): 52-60, 2017

Essential oils composition of Iranian Artemisia absinthium L. and Artemisia scoparia Waldst. et Kit. Journal of essential oil research: JEOR e 17(3): 321-322, 2005

Chemical composition of the essential oils of serbian wild-growing Artemisia absinthium and Artemisia vulgaris. Journal of Agricultural and Food Chemistry 54(13): 4780-4789, 2006

Morphological and anatomical characteristics of Artemisia absinthium var absinthium and its Polish endemic variety A absinthium var calcigena. Plant Systematics and Evolution 298(7): 1325-1336, 2012

Therapeutic efficacy of Artemisia absinthium against Hymenolepis nana: in vitro and in vivo studies in comparison with the anthelmintic praziquantel. Journal of Helminthology 92(3): 298-308, 2018

Extracts of Artemisia abrotanum and Artemisia absinthium inhibit growth of Naegleria fowleri in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene 85(1): 78-79, 1991

In vitro evaluation of ethanolic extracts of Ageratum conyzoides and Artemisia absinthium against cattle tick, Rhipicephalus microplus. Thescientificworldjournal 2014: 858973, 2014

The essential oil components from artemisia absinthium. Zeitschrift fuer Naturforschung Section C Journal of Biosciences 36(5-6): 369-377, 1981

Normal-phase high-performance thin-layer chromatography and automated multiple development of hydroalcoholic extracts of Artemisia abrotanum Artemisia absinthium, Artemisia vulgaris and Artemisia cinia. Journal of Planar Chromatography - Modern TLC 11(5): 361-364, 1998

Essential oil of Artemisia absinthium L. from the Spanish Pyrenees. Journal of Essential Oil Research 11(2): 182-184, 1999

Some phytochemical characteristics of Artemisia absinthium L. essential oil. Herba Hungarica 21(2/3): 197-215, 1982